Tanya T. Kwan

ATR inhibition disrupts rewired homologous recombination and fork protection pathways in PARP inhibitor-resistant BRCA-deficient cancer cells

Stephanie A. Yazinski, Valentine Comaills, Rémi Buisson et al. · Genes & Development · 2017 · 386 citations · Full text

Replication Fork Protection, Genome Instability, Health Sciences +15

Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy

Dirk Zboralski, Aileen Hoehne, Anne Bredenbeck et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2022 · 230 citations · Full text

Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

Elizabeth M. Swisher, Tanya T. Kwan, Amit M. Oza et al. · Nature Communications · 2021 · 193 citations · Full text

An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma

Mark Kalinich, Irun Bhan, Tanya T. Kwan et al. · Proceedings of the National Academy of Sciences · 2017 · 156 citations · Full text

An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer

David T. Miyamoto, Richard J. Lee, Mark Kalinich et al. · Cancer Discovery · 2018 · 133 citations · Full text